Treating ALL patients with T cells targeted for CD19

Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA
Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )
8 Dec 2013

Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL

Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia

Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta  T cells and of CD19  B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013

Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531

Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013

IMCPO, legal aspects of being an oncologist and the latest treatment for lung cancer in India

Dr Purvish Parikh - President of the Indian Society for Medical and Paediatric Oncology (ISMPO)
IMCPO, legal aspects of being an oncologist and the latest treatment for lung cancer in India ( Dr Purvish Parikh - President of the Indian Society for Medical and Paediatric Oncology (ISMPO) )
4 Dec 2013

Childhood cancer registries in Africa

Dr Daniela Cristina Stefan - Stellenbosch University & Tygerberg Hospital, South Africa
Childhood cancer registries in Africa ( Dr Daniela Cristina Stefan - Stellenbosch University & Tygerberg Hospital, South Africa )
2 Dec 2013

Pathology and diagnosis of nephroblastoma

Dr Gordan Vujanic – University of Cardiff, UK
Pathology and diagnosis of nephroblastoma ( Dr Gordan Vujanic – University of Cardiff, UK )
27 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

ecancerNews November Round Up

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews November Round Up ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013

Editor’s Choice - ecancermedicalscience August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor’s Choice - ecancermedicalscience August 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
8 Aug 2013